So here is a link to the Silicon Valley Bank review of the Biotech Market. With the recent acquisition of Celgene by Bristol Myers for a whopping price, other acquisitions will follow in our space. At a low valuation, GLG Pharma with its clinical candidates would make a perfect target for an IPO and or an acquisition. Here is the link!!!
You'll need to click on the second link to download the PDF copy. Cheers to all!!
Privacy: We won’t share your data, or post to your wall, without your permission.
Already have an account? Login
Don't have an account? Signup